EFFECTS OF AGE-RELATED ANDROGEN DEFICIENCY ON CLINICOPSYCHOLOGICAL CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE

被引:0
作者
Kravchenko, A. Ya.
Provotorov, V. M.
机构
关键词
age-related androgen deficiency; ischemic heart disease; male sex; depression;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study prevalence of androgen deficiency and its relations with clinicopsychological disorders in males with ischemic heart disease (IHD). Material and methods. A total of 87 males aged 31-60 years (58 with stable angina of effort FCII-III, 29 with progressive angina of effort) participated in the study. Clinical symptoms of androgen deficiency, severity of anxiety and depression, quality of life were characterized with scales AMS, HADS, D.M. Aronov and V.P. Zaitsev method (2002), respectively. Left ventricular myocardial mass (LVMM) was calculated according to R.Devereux and N. Reichek formula. Results. Symptoms of male sexual hormones deficiency were seen in 67.8% examinees. In the age groups 31-40, 41-50, 51-60 years androgenic deficiency was diagnosed in 50, 85.7 and 82.9% patients, respectively. A direct correlation was found between androgenic deficiency and total cholesterol (R = 0.38), prothrombin index (R = 0.39), LVMM index (R = 0.48), severity of depression (R = 0.71), anxiety (R = 0.5) and inverse correlation - between androgenic deficiency and quality of life (R = -0.69). Conclusion. Young and middle-aged patients with ischemic heart disease have symptoms of androgenic deficiency in 67.8% cases. This fact necessitates screening testing of such patients with AMS questionnaire. Male sex hormones deficiency is associated with high anxiety and depression, while quality of life is subnormal.
引用
收藏
页码:10 / 13
页数:4
相关论文
共 14 条
  • [1] Aronov DM, 2002, KARDIOLOGIYA, V42, P92
  • [3] DEDOV II, 2006, VOZRAST ANDROGEN DEF
  • [4] ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD
    DEVEREUX, RB
    REICHEK, N
    [J]. CIRCULATION, 1977, 55 (04) : 613 - 618
  • [5] DUNBAR N, 2001, AGING MALE, V4, P1
  • [6] AN EXAMINATION OF RESEARCH DESIGN EFFECTS ON THE ASSOCIATION OF TESTOSTERONE AND MALE AGING - RESULTS OF A METAANALYSIS
    GRAY, A
    BERLIN, JA
    MCKINLAY, JB
    LONGCOPE, C
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (07) : 671 - 684
  • [7] Low levels of endogtenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study
    Hak, AE
    Witteman, JCM
    de Jong, FH
    Geerlings, MI
    Hofman, A
    Pols, HAP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) : 3632 - 3639
  • [8] Heinemann LAJ, 1999, AGING MALE, V2, P105, DOI DOI 10.3109/13685539909003173
  • [9] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    Hulley, S
    Grady, D
    Bush, T
    Furberg, C
    Herrington, D
    Riggs, B
    Vittinghoff, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 605 - 613
  • [10] Testosterone for secondary prevention in men with ischaemic heart disease?
    Malkin, CJ
    Pugh, PJ
    Jones, TH
    Channer, KS
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (07) : 521 - 529